Mingxuan Feng
- Cancer Research top 5%
- Hepatology top 5%
- Liver Disease and Transplantation 8
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Molecular Biology top 10%
- Bone Metabolism and Diseases 4
-
- Organ Transplantation Techniques and Outcomes 8
- Pediatric Hepatobiliary Diseases and Treatments 6
- Transplantation: Methods and Outcomes 3
-
- SARS-CoV-2 and COVID-19 Research 4
-
- Renal Transplantation Outcomes and Treatments 3
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Mingxuan Feng
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 488
- Hepatology 122
- Molecular Biology 857
- Oncology 210
- Cell Biology 88
Countries citing papers authored by Mingxuan Feng
This map shows the geographic impact of Mingxuan Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxuan Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxuan Feng more than expected).
Fields of papers citing papers by Mingxuan Feng
This network shows the impact of papers produced by Mingxuan Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxuan Feng. The network helps show where Mingxuan Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingxuan Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 19 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 3 | |
| 17 | 2019 | 268 | |
| 18 | 2018 | 90 | |
| 19 | 2018 | 32 | |
| 20 | 2016 | 49 |
About Mingxuan Feng
Mingxuan Feng is a scholar working on Hepatology, Transplantation and Cancer Research, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (8 papers), Organ Transplantation Techniques and Outcomes (8 papers), Pediatric Hepatobiliary Diseases and Treatments (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Bone Metabolism and Diseases (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Cancer Research (488 citations), Hepatology (122 citations) and Molecular Biology (857 citations). Mingxuan Feng has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Zhigang Zhang, Qiang Xia, Xiaomei Yang, Yahui Wang, Jun Li, Jianren Gu, Wenxin Qin, Shu‐Heng Jiang, Yanli Zhang and Zhenjun Zhao. Their work appears in journals such as Gastroenterology, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.